tct highlights: long-term outcomes of beti-cel gene therapy for β-thalassemia
Published 2 years ago • 180 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
8:57
outcomes of sct in t-all and t-lbl
-
0:35
tct 2021: what to look forward to
-
2:48
out of specification tisagenlecleucel in real-world treatment of pediatric b-all
-
6:50
a new therapeutic target in t-all
-
7:04
ttsh unveils new care model for musculoskeletal conditions
-
0:32
tcellsrealtime
-
1:09
john koo, md - does a patient with latent tb need treatment before using ruxolitinib cream?
-
1:25
improving latent tuberculosis infection treatment completion rates
-
5:54
redirectt-1 results: teclistamab talquetamab in r/r multiple myeloma
-
0:51
tracoe time lapse video - the making of lumy
-
6:08
ttsh - the early years
-
0:18
latent tb: animated into action - snippit
-
5:30
linvoseltamab versus teclistamab for tce rrmm and the sequencing of bispecifics with car-ts
-
1:30
save contrast, radiation, time with 3d roadmap technology
-
2:01
eradicating tb from the modern world
-
2:40
ttsh visitor facilitation system
-
1:49
prevent #tb to #endtb
-
1:23
research treatment length for children with tuberculosis now reduced